Health Trials

Efficacy and Safety of Piemonte Association in the Treatment of Type II Diabetes Mellitus

ConditionType II Diabetes
Trial statusRecruiting
Trial phasePhase 3
Trial typeInterventional
Biological sexAll
Age18-85
SponsorEMS

About this trial

The purpose of this study is to evaluate the efficacy and safety of Piemonte association in the treatment of type 2 diabetes mellitus

Eligibility criteria

Qualifiers

Ability to confirm voluntary participation and agree to all trial purposes by signing and dating the consent form;

Diagnosis of type II diabetes mellitus, and who did not reach the therapeutic goal of HbA1c with previous dietary, physical exercise, and previous therapies at stable doses within 3 months.

Disqualifiers

Any clinical and laboratory findings that, in the judgment of the investigator, may interfere with the safety of participants;

History of alcohol abuse or illicit drug use;

Participation in a clinical trial in the year prior to this study;

Pregnancy or risk of pregnacy and lactating participants;

Trial design

Treatments tested in this trial

  • PIEMONTE
  • PIEMONTE PLACEBO
  • EMPAGLIFLOZIN
  • PLACEBO EMPAGLIFLOZIN
  • PIOGLITAZONE
  • PLACEBO PIOGLITAZONE

Treatment groups

480 Participants
are divided into 3 treatment groups

Sponsors and collaborators

EMS

Lead sponsor

Source ClinicalTrials.gov